CHEOF
Price
$195.55
Change
+$2.51 (+1.30%)
Updated
Jul 25 closing price
Capitalization
10.47B
FSPKF
Price
$20.01
Change
-$2.09 (-9.46%)
Updated
Jul 23 closing price
Capitalization
8.78B
Interact to see
Advertisement

CHEOF vs FSPKF

Header iconCHEOF vs FSPKF Comparison
Open Charts CHEOF vs FSPKFBanner chart's image
CochLear
Price$195.55
Change+$2.51 (+1.30%)
Volume$17
Capitalization10.47B
Fisher & Paykel Healthcare
Price$20.01
Change-$2.09 (-9.46%)
Volume$160
Capitalization8.78B
CHEOF vs FSPKF Comparison Chart in %
Loading...
CHEOF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
FSPKF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CHEOF vs. FSPKF commentary
Jul 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CHEOF is a Buy and FSPKF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 27, 2025
Stock price -- (CHEOF: $195.55 vs. FSPKF: $20.01)
Brand notoriety: CHEOF and FSPKF are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: CHEOF: 5% vs. FSPKF: 25%
Market capitalization -- CHEOF: $10.47B vs. FSPKF: $8.78B
CHEOF [@Medical Specialties] is valued at $10.47B. FSPKF’s [@Medical Specialties] market capitalization is $8.78B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.67B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CHEOF’s FA Score shows that 1 FA rating(s) are green whileFSPKF’s FA Score has 0 green FA rating(s).

  • CHEOF’s FA Score: 1 green, 4 red.
  • FSPKF’s FA Score: 0 green, 5 red.
According to our system of comparison, CHEOF is a better buy in the long-term than FSPKF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CHEOF’s TA Score shows that 3 TA indicator(s) are bullish while FSPKF’s TA Score has 3 bullish TA indicator(s).

  • CHEOF’s TA Score: 3 bullish, 4 bearish.
  • FSPKF’s TA Score: 3 bullish, 3 bearish.
According to our system of comparison, FSPKF is a better buy in the short-term than CHEOF.

Price Growth

CHEOF (@Medical Specialties) experienced а -5.85% price change this week, while FSPKF (@Medical Specialties) price change was -9.46% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +3.01%. For the same industry, the average monthly price growth was +4.92%, and the average quarterly price growth was -2.24%.

Reported Earning Dates

FSPKF is expected to report earnings on May 28, 2025.

Industries' Descriptions

@Medical Specialties (+3.01% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CHEOF($10.5B) has a higher market cap than FSPKF($8.78B). CHEOF has higher P/E ratio than FSPKF: CHEOF (60.61) vs FSPKF (55.87). CHEOF YTD gains are higher at: 7.414 vs. FSPKF (-0.941). CHEOF (434M) and FSPKF (434M) have comparable annual earnings (EBITDA) . CHEOF has more cash in the bank: 629M vs. FSPKF (121M). FSPKF has less debt than CHEOF: FSPKF (146M) vs CHEOF (254M). CHEOF has higher revenues than FSPKF: CHEOF (1.71B) vs FSPKF (1.59B).
CHEOFFSPKFCHEOF / FSPKF
Capitalization10.5B8.78B120%
EBITDA434M434M100%
Gain YTD7.414-0.941-788%
P/E Ratio60.6155.87108%
Revenue1.71B1.59B108%
Total Cash629M121M520%
Total Debt254M146M174%
FUNDAMENTALS RATINGS
CHEOF vs FSPKF: Fundamental Ratings
CHEOF
FSPKF
OUTLOOK RATING
1..100
3997
VALUATION
overvalued / fair valued / undervalued
1..100
13
Undervalued
93
Overvalued
PROFIT vs RISK RATING
1..100
54100
SMR RATING
1..100
4246
PRICE GROWTH RATING
1..100
5852
P/E GROWTH RATING
1..100
8097
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CHEOF's Valuation (13) in the null industry is significantly better than the same rating for FSPKF (93). This means that CHEOF’s stock grew significantly faster than FSPKF’s over the last 12 months.

CHEOF's Profit vs Risk Rating (54) in the null industry is somewhat better than the same rating for FSPKF (100). This means that CHEOF’s stock grew somewhat faster than FSPKF’s over the last 12 months.

CHEOF's SMR Rating (42) in the null industry is in the same range as FSPKF (46). This means that CHEOF’s stock grew similarly to FSPKF’s over the last 12 months.

FSPKF's Price Growth Rating (52) in the null industry is in the same range as CHEOF (58). This means that FSPKF’s stock grew similarly to CHEOF’s over the last 12 months.

CHEOF's P/E Growth Rating (80) in the null industry is in the same range as FSPKF (97). This means that CHEOF’s stock grew similarly to FSPKF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CHEOFFSPKF
RSI
ODDS (%)
Bearish Trend 2 days ago
60%
Bullish Trend 2 days ago
52%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
55%
Bullish Trend 2 days ago
62%
Momentum
ODDS (%)
Bearish Trend 2 days ago
54%
Bearish Trend 2 days ago
60%
MACD
ODDS (%)
Bearish Trend 2 days ago
52%
Bearish Trend 2 days ago
51%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
54%
Bearish Trend 2 days ago
52%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
46%
Bearish Trend 2 days ago
43%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
56%
N/A
Aroon
ODDS (%)
Bullish Trend 2 days ago
42%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
CHEOF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
FSPKF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
OVS33.740.18
+0.55%
Overlay Shares Small Cap Equity ETF
VIDI30.590.08
+0.27%
Vident International Equity Strategy ETF
BKAG41.880.09
+0.22%
BNY Mellon Core Bond ETF
IGBH24.350.04
+0.15%
iShares Interest Rate Hdg L/T Corp BdETF
PBJN28.68N/A
N/A
PGIM S&P 500 Buffer 20 ETF - Jun

CHEOF and

Correlation & Price change

A.I.dvisor tells us that CHEOF and FSPKF have been poorly correlated (+21% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CHEOF and FSPKF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CHEOF
1D Price
Change %
CHEOF100%
+1.30%
FSPKF - CHEOF
21%
Poorly correlated
N/A
A - CHEOF
20%
Poorly correlated
-0.14%
CHEOY - CHEOF
15%
Poorly correlated
N/A
BMXMF - CHEOF
11%
Poorly correlated
+10.61%
CALZF - CHEOF
11%
Poorly correlated
-1.08%
More

FSPKF and

Correlation & Price change

A.I.dvisor tells us that FSPKF and ANSLY have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that FSPKF and ANSLY's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FSPKF
1D Price
Change %
FSPKF100%
N/A
ANSLY - FSPKF
26%
Poorly correlated
N/A
OLYMY - FSPKF
25%
Poorly correlated
-0.98%
TMDX - FSPKF
25%
Poorly correlated
+1.25%
BRSYF - FSPKF
22%
Poorly correlated
N/A
TCHBF - FSPKF
22%
Poorly correlated
N/A
More